Artikel
Öffentlich zugänglich
Frontmatter
Veröffentlicht/Copyright:
14. November 2024
Published Online: 2024-11-14
©2024 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Review
- Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
- Research Articles
- Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis
- Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery
- Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
Artikel in diesem Heft
- Frontmatter
- Review
- Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
- Research Articles
- Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis
- Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery
- Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
